No Data
No Data
Forte Biosciences: Key Outcomes From 2024 Stockholders Meeting
Express News | Chardan Capital Maintains Buy on Forte Biosciences, Maintains $3 Price Target
Express News | Forte Biosciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results
Forte Biosciences | 10-Q: Q2 2024 Earnings Report
Express News | Forte Biosciences Q2 Basic EPS USD -0.27
Express News | Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update
No Data